ArticleFrontiers in endocrinology2026
Trajectory models of serum creatinine and 28-day mortality in critically ill patients with sepsis complicated by type 2 diabetes mellitus: a cohort study.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: In critically ill patients with sepsis complicated by type 2 diabetes mellitus (T2DM), renal dysfunction is prevalent; however, the association between dynamic serum creatinine trajectory patterns and short-term mortality risk remains inadequately characterized. Methods: This study was conducted using data from the Medical Information Mart for Intensive Care IV (MIMIC-IV) database. The target population comprised adult intensive care unit (ICU) patients with sepsis complicated by T2DM. Group-Based Trajectory Modeling (GBTM) was employed to categorize the patterns of serum creatinine changes within 72 hours following ICU admission. Multivariable Cox proportional hazards models and Kaplan-Meier (K-M) survival curves were constructed to assess the association between trajectory groups and 28-day all-cause mortality, while restricted cubic spline (RCS) curves were utilized to examine the trend of short-term mortality risk in relation to serum creatinine levels. Furthermore, subgroup analyses and mediation effect analysis of continuous renal replacement therapy (CRRT) were performed. Results: A total of 1909 patients were included in the study, with 439 deaths occurring within 28 days, corresponding to a 28-day all-cause mortality rate of approximately 23.0%. Three distinct serum creatinine trajectory patterns were identified: low-stable, moderate-increasing, and persistently high. Compared with the low-stable trajectory group, patients in the moderate-increasing and persistently high groups exhibited significantly elevated 28-day mortality risk, which remained statistically significant following multivariable adjustment, with adjustments for age, gender, temperature, platelet count, albumin, blood urea nitrogen, pH, renal disease, severe liver disease, mechanical ventilation, 24-hour urine output, and the Charlson Comorbidity Index (model 2: HR = 1.50, 95% CI: 1.16-1.93, p = 0.02; model 3: HR = 1.46, 95% CI: 1.04-2.05, p = 0.03). RCS analysis revealed a significant nonlinear association between serum creatinine levels and mortality risk. The subgroup analysis results revealed significant interaction effects across gender and CRRT subgroups. Mediation analysis demonstrated that CRRT may exert a partial mediating effect on the association between creatinine elevation and mortality risk. Conclusion: The early trajectory of serum creatinine changes following ICU admission is independently associated with 28-day mortality in critically ill patients with sepsis complicated by T2DM. Sustained higher serum creatinine levels are significantly associated with an increased risk of mortality.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.